TABLE 2.
Subtypes | Subsets and distribution (Human) | Functions and mechanism (Mice) | References |
NKT | (1) IFN-γ+NKT in SF of RA; (2) RORγt+T-betlowPLZF– iNKT with Th17-like response in joints of PsA and other SpA. |
(1) IL-17+ NKT promote murine arthritis; (2) CD1d-dependent NKT protect murine arthritis by dampening Th1 cell responses; (1) Dampening combined gut and joint inflammation in SpA. |
(55–64) |
MAIT | (1) MAIT with IL-17 phenotype in SF of RA; (2) CD8+IL-17+IL-23R+ MAIT in SF of PsA; (3) CD8+IL-17+IL-23R+IL-7R+ MAIT in SF of SpA. |
(1) MAIT exacerbate in murine CIA model; (2) IL-23/IL-17 axis in MAIT contribute to PsA; (3) IL-7/IL-17 axis in MAIT contribute to AS and other SpA. |
(66–71) |
γδ17 T | (1) CCR5+CXCR3+ IL-17-producing Vδ2 T in RA; (2) TEM Vγ9+Vδ2+ IL-17-producing T cells with HLA-DR and CD86 expression in SF of RA; (3) TEMγδ17 T cells in peripheral and synovium of PsA; (4) IL-23R+RORγt+ γδ17 T cells in active AS and other SpA. |
(1) In CIA murine arthritis, IL-17 producing Vγ4+ γδ T promoted disease development; (2) In Il1rn–/– spontaneously developed arthritis, CCR2+Vγ6+ γδ17 T cells participate in disease progression. |
(29, 62, 78–84) |
Innate-like B | (1) Reduced B10 cells in PBMC of RA; (2) Impaired B10 cells in PBMC and SF of PsA; (3) CD19+CD24hiCD38hi B10 cells decreased in PBMC and SF of SpA |
(1) CII-reactive MZB cells exhibit spontaneous IgM and significant APC capacity for murine arthritis development; (2) B10 is crucial for suppression of Th1/Th17 response and induction of T regulatory type 1 cells; (3) B10 directly inhibit Th17 cells generation via reduction of STAT3 phosphorylation and RORγt expression; (1) B10 present CD1d-lipid and induced iNKT cells to secrete IFN-γ to ameliorate arthritis. |
(89–99) |